Lyell Immunopharma

Venture Capital

Lyell Immunopharma is a Venture Capital firm.

Lyell is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer.

Biotech
Website
Website
lyell.com
Portfolio Company
1
Recorded investments
1
Latest recorded investment
Sep 2020
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/lyell-immunopharma?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 1 portfolio company and 1 funding round for this investor. to use credits for reveals, or explore the API.

Overview

Indexed has recorded 1 investment for Lyell Immunopharma. Its portfolio includes Sonoma Biotherapeutics. Focus areas include Biotech.

Portfolio1

Co-investors8

Sign up to view co-investors

Up to 24 co-investors shown

Venture Capital ×6 · Corporate VC ×2

Recorded investments1

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Lyell Immunopharma on Indexed.vc
<a href="https://indexed.vc/investors/lyell-immunopharma"><img src="https://indexed.vc/api/badge/investor/lyell-immunopharma" alt="Lyell Immunopharma on Indexed.vc" width="260" height="76" /></a>